Nippon India Pharma Fund - Direct Plan - Growth Plan
Add To Comparepreviously known as Reliance Pharma Dir Gr until
NAV on January 16, 2026
Category
Equity:
Sector - Healthcare
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets
8,265 cr
Turnover Ratio
14.27%
Expense Ratio
0.91%
Exit Load
1.00%
if redeemed within
Returns
- 1M: -1.52%
- 1Y: 1.60%
- 3M: -2.14%
- 3Y: 22.22%
- 6M: -4.15%
- 5Y: 15.23%
Best Sector Healthcare Funds
| NAME | LATEST NAV |
RETURNS 1y |
FUND ASSETS |
Expense RATIO |
RISK | |
| 484.443 | 1.23% | 3,989 cr | 0.91% | - | ||
Other plans of Nippon India Pharma